Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION USP

Last updated on 2020-09-03 History
Report ID 112293
Drug Identification Number 02485540
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Common or Proper name Hydromorphone Hydrochloride Injection USP
Company Name STERINOVA INC.
Market Status MARKETED
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 40MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size Box of 30 x 100 mL
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-04-17
Actual start date 2020-04-17
Estimated end date 2020-08-31
Actual end date 2020-08-31
Shortage status Resolved
Updated date 2020-09-03
Company comments Resolved
Health Canada comments
Tier 3 Status No
Contact Address 3005 AVENUE JOSE-MARIA ROSELL
SAINT-HYACINTHE, QUEBEC
CANADA J2S 0J9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-09-03 English Compare
v3 2020-04-18 English Compare
v2 2020-04-15 French Compare
v1 2020-04-15 English Compare

Showing 1 to 4 of 4